These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 9144232)
1. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232 [TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of PML/RARalpha impairs myelopoiesis. Early E; Moore MA; Kakizuka A; Nason-Burchenal K; Martin P; Evans RM; Dmitrovsky E Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7900-4. PubMed ID: 8755574 [TBL] [Abstract][Full Text] [Related]
3. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740 [TBL] [Abstract][Full Text] [Related]
4. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Brown D; Kogan S; Lagasse E; Weissman I; Alcalay M; Pelicci PG; Atwater S; Bishop JM Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2551-6. PubMed ID: 9122233 [TBL] [Abstract][Full Text] [Related]
5. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha. Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585 [TBL] [Abstract][Full Text] [Related]
6. The molecular genetics of acute promyelocytic leukemia. Grignani F; Fagioli M; Ferrucci PF; Alcalay M; Pelicci PG Blood Rev; 1993 Jun; 7(2):87-93. PubMed ID: 8396481 [TBL] [Abstract][Full Text] [Related]
7. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078 [TBL] [Abstract][Full Text] [Related]
8. A bcr3/short form PML-RARalpha transcript in an acute promyelocytic leukemia resulted from a derivative chromosome 17 due to submicroscopic insertion of the PML gene into the RARalpha locus. Wang HY; Ding J; Vasef MA; Wilson KS Am J Clin Pathol; 2009 Jan; 131(1):64-71. PubMed ID: 19095567 [TBL] [Abstract][Full Text] [Related]
9. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia. Matsushita H; Scaglioni PP; Bhaumik M; Rego EM; Cai LF; Majid SM; Miyachi H; Kakizuka A; Miller WH; Pandolfi PP J Exp Med; 2006 Apr; 203(4):821-8. PubMed ID: 16549595 [TBL] [Abstract][Full Text] [Related]
11. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265 [TBL] [Abstract][Full Text] [Related]
12. The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha. Occhionorelli M; Santoro F; Pallavicini I; Gruszka A; Moretti S; Bossi D; Viale A; Shing D; Ronzoni S; Muradore I; Soncini M; Pruneri G; Rafaniello P; Viale G; Pelicci PG; Minucci S Leukemia; 2011 May; 25(5):814-20. PubMed ID: 21331069 [TBL] [Abstract][Full Text] [Related]
13. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells. Nason-Burchenal K; Allopenna J; Bègue A; Stéhelin D; Dmitrovsky E; Martin P Blood; 1998 Sep; 92(5):1758-67. PubMed ID: 9716606 [TBL] [Abstract][Full Text] [Related]
14. Differentiation response of acute promyelocytic leukemia cells and PML/RARa leukemogenic activity studies by real-time RT-PCR. Caprodossi S; Pedinotti M; Amantini C; Santoni G; Minucci S; Pelicci PG; Fanelli M Mol Biotechnol; 2005 Jul; 30(3):231-8. PubMed ID: 15988048 [TBL] [Abstract][Full Text] [Related]
15. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752 [TBL] [Abstract][Full Text] [Related]
16. Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Pandolfi PP Hum Mol Genet; 2001 Apr; 10(7):769-75. PubMed ID: 11257111 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia. Kane JR; Head DR; Balazs L; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Behm FG; Krance RA; Shurtleff SA; Downing JR Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634 [TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia: from clinic to molecular biology. Chen SJ; Wang ZY; Chen Z Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245 [TBL] [Abstract][Full Text] [Related]
19. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia. Grimwade D; Solomon E Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677 [TBL] [Abstract][Full Text] [Related]
20. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]